(4-(N-Benzylsulfamoyl)phenyl)boronic acid, 95.0%, 250mg

5-Hydroxynorbornane 2,6-Lactone>98.0%(GC)5g

Volumetric flasks with glass stopper, class A Trapezoidal shape, 25 ml, 10/19, 2 Piece(s)

2-methyl-3,4-dihydropyrimidin-4-one, 98%, 1g

(R)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 100mg

Methyl 6-amino-2-methylnicotinate, 97%, 1g

2-tert-Butyloxycarbonylaminomethyl-5-(3-chlorophenyl)-[1,3,4]oxadiazole, 95.0%, 1g

2,2-Difluoropropionic acid, 98.0%, 25g

Methyl 3,6-difluoro-2-hydroxybenzoate, 95+%, 250mg

C-[5-(4-Fluoro-phenyl)-2-methyl-furan-3-yl]-methylamine, 95.0%, 1g

4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

Ethyl 2-hydroxyacetate, 95.0%, 500g

5-Bromopyridazin-3-amine, 1g